Due to the growing COVID-19 pandemic, the FDA asked Judge Paul Grimm of the United States Court of Appeals for the Fourth Circuit Counsel to allow them to extend the Premarket Tobacco Product Application (PMTA) deadline for nicotine vapor products by 120 days.
Opponents of Tobacco Harm Reduction are upset, with vocal critic Stan Glantz saying this protects the vapor technology community.
On the other side of the debate, people eager to help their loved ones quit smoking during the Coronavirus epidemic are thankful to have more time to get and stay off cigarettes. People who regularly use cigarettes face additional risk of hospitalization and death from COVID-19. The FDA’s PMTA process, which was not designed for nicotine vapor technology products, is expected to effectively ban the vast majority of safer nicotine products available to help people quit smoking.